Phase 4 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 65 years old or younger
- People whose vital signs (such as heart rate, blood pressure, and breathing) are stable
- People who do not have a severe infection
- People who do not have a moderate-to-severe immune reaction known as graft-versus-host disease (Grade II–IV) (confirm with trial site)
- People whose major organs are functioning normally
Who may not be able to join:
- People who are older than 65 years
- People whose vital signs are unstable
- People who have a severe infection
- People who have moderate-to-severe graft-versus-host disease (Grade II–IV), which is a condition where transplanted cells react against the body (confirm with trial site)
- People who have failure of major organs such as the heart, liver, or kidneys
- People who have leukemia that has spread to the central nervous system (the brain and spinal cord)
- People who have known allergies to any of the medications used in the trial's treatment plan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhilei BIAN, The First Affiliated Hospital of Zhengzhou University
Phone: +8613523510641
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival; Disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.